Email Us
View Reports

Emergent Biosolutions Inc. Company Profile - Overview, History, SWOT Analysis, Products/Services, Facts, Financials, Key Executives, Competitors, Tech Intelligence, IT Outsourcing, IT Management, Recent Developments and Strategy Evaluation

  • ID : 3649369  |  
  • Published : Apr-2018  |  
  • Region : Global  |  
  • Pages : 37   |  
  • Publisher : Market Data Forecast

Emergent BioSolutions Inc. (Emergent) provides the healthcare providers and governments with products that are used in addressing medical needs and health threats. The company operates in the US, the UK, Germany, Malaysia, Singapore, and Australia. The company classifies its business into four business units: Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Manufacturing. Emergent’s Vaccines and Anti-Infectives business unit consists of BioThrax, the US FDA licensed vaccine for the general use prophylaxis of anthrax disease. It also develops NuThrax, a next generation anthrax vaccine. The company leverages its broad-spectrum anti-viral and broad-spectrum antibiotic platforms for the development of molecules to address current and emerging public health threats. The Antibody Therapeutics business unit consists of Anthrasil, used for the treatment of inhalational anthrax; BAT, for the treatment of botulinum disease; and VIGIV, to address complications from smallpox vaccination. The company leverages its hyper immune platform technology to address current and emerging public health threats including Influenza and Zica. Emergent’s Devices business unit consists of RSDL, to remove or neutralize chemical warfare agents and T-2 toxins from the skin; and Trobigard for the intramuscular self-injection as a nerve agent countermeasure. The company leverages on its proprietary, auto-injector platform to develop several investigational stage product candidates. The Contract Manufacturing business unit is involved in contract manufacturing services to third-party customers. It manufactures vial and pre-filled syringe formats and bulk drug product and finished units of clinical and commercial drugs. The company provides these services for a variety of drug products including small molecule, biological, and blood products across stages of development and commercialization. The company manufactures BioThrax products in Lansing, Michigan. It also has facility focusing on disposable manufacturing for viral and non-viral products located in Baltimore, Maryland. The company has other manufacturing facilities and other capabilities in Winnipeg, Manitoba, Canada. Emergent's subsidiaries are Cangene bioPharma, Emergent Protective Products USA, Cangene Corporation, Emergent BioSolutions Malaysia SDN BHD, Emergent Product Development UK Limited, Emergent Protective Products Canada ULC, Emergent Sales and Marketing Australia Pty Limited, Emergent Sales and Marketing Singapore Pte. Ltd, and Emergent Product Development Germany GmbH

Scope of the Report

-- About the Company - Historical Details, Current Ownership Structure and basic overview of Emergent Biosolutions Inc. in terms of revenue, net income, and operating income.

-- Financials - Details about Emergent Biosolutions Inc. listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.

-- Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.

-- Company SWOT Analysis - Outlines Emergent Biosolutions Inc.’s strengths, weaknesses, and opportunities and threats facing the company.

-- Recent Developments - Showcases Emergent Biosolutions Inc.’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.

-- Strategic Evaluation - Provides an overview of Emergent Biosolutions Inc.’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.

-- Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.

Key Questions Answered

-- What domain does Emergent Biosolutions Inc. operate and what are key points about it?

-- What is the product / service portfolio of Emergent Biosolutions Inc.?

-- How has Emergent Biosolutions Inc. performed financially from the 2013?

-- How does Emergent Biosolutions Inc. rank among its peers in terms of revenue and market share?

-- What are Emergent Biosolutions Inc. strengths and weaknesses and what opportunities and threats does it face?

-- What are Emergent Biosolutions Inc.’s main growth strategies and how successful has the company been at implementing them?

-- What is the in-house technical capability of Emergent Biosolutions Inc.? Where does it procure / outsource it?

Reasons to buy

-- Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own

-- Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost

-- 12 hour delivery time fulfilling your urgent requests as per your requirement

-- On-demand customization options that can completely cater to your needs by focusing the report onto given specifics

1. About the Company

1.1 History and Basic Facts

1.2 Ownership Structure and Key Executives

1.3 Head Office

1.4 Other Locations & Subsidiaries

1.5 List of Competitors

1.6 Employee Count & Distribution

2. Financials

2.1 Company Type (Listed / Unlisted)

2.2 Annual Statements

2.3 Key Financial Highlights

2.4 Region-wise Breakdown

3. Product / Services

3.1 Overview

3.2 Description

4. SWOT Analysis

4.1 SWOT Overview

4.2 Strengths

4.3 Weaknesses

4.4 Opportunities

4.5 Threats

5. Recent Developments

5.1 Mergers & Acquisitions

5.2 Partnerships, Collaborations & Joint Ventures

5.3 New Product Launches

5.4 Business Expansion / Divestment

6. Strategic Evaluation

6.1 Corporate Strategy

6.2 Legal Issues

6.3 Analyst Outlook

7. Technology Landscape

7.1 Industry

-- 7.1.1 Industry Snapshot

-- 7.1.2 IT Spend

-- 7.1.3 Key Information Technology Trends

7.2 Company

-- 7.2.1 IT Overview

-- 7.2.2 Key IT Technologies

-- 7.2.3 Recent IT Initiatives

-- 7.2.4 IT Outsourcing Engagements

-- 7.2.5 Key IT Management

-- 7.2.6 CIO/CTO Profile

Appendix

-- Methodology

-- About Us

-- Contact Us

-- Disclaimer

Fig.1: Company Snapshot

Fig.2: Locations Listing on Map

Table.1: Ownership Structure

Table.2: List of Competitors

Table.3: Annual Statements

Table.4: Key Financial Highlights

Table.5: Region-wise Breakdown

Table.6: Product/Services Overview

Table.7: Mergers & Acquisitions

Table.8: Partnerships, Collaborations & Joint Ventures

Table.9: New Product Launches

Table.10: Business Expansion / Divestment

Table 11: IT Budgets

Table 12: Key IT Management (CIO / CTO)

Table 13: IT Deals undertaken in the past years

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?